Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 3 days ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 9 months ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - 10 months ago New Oral Drug Approved for Metastatic Colorectal Cancer - 10 months ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 4 days ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 27 days ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 27 days ago FDA Approves Roflumilast for Atopic Dermatitis in Patients 6 Years and Older - 2 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 3 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 3 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 6 months ago FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients - 6 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 7 months ago FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma - 7 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 9 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - 10 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - 10 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - 10 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - 10 months ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - 11 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 27 days ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago Year in Review: Follicular Lymphoma - 10 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - 10 months ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - 10 months ago RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer - 11 months ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - about 1 month ago FDA Grants Accelerated Approval of Resmetirom for Noncirrhotic Nonalcoholic Steatohepatitis With Moderate to Advanced Liver Fibrosis - 6 months ago
5	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Medicare Lags, Medicaid Leads for Biosimilar Uptake - about 2 months ago Novel Drug OK'd for Ulcerative Colitis - 11 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal - 2 months ago Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease - 3 months ago
7	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 2 months ago Regorafenib-Pembrolizumab Has 'Modest' Activity in HCC Post-Immunotherapy - 3 months ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - 8 months ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - 8 months ago Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma - 9 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - 9 months ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - 10 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 10 months ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - 10 months ago Guselkumab for PsA Yields 'Meaningful Improvements' in Quality of Life - 10 months ago A Novel Mechanism of Action in Treating Relapsing MS - 10 months ago New Data on CD40 Ligand Inhibitor for Relapsing MS - 10 months ago Guselkumab Shows Early Symptom Improvement in UC - 10 months ago
8	Kristen Monaco MedPage Today	Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 3 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 6 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 10 months ago Sparsentan Failed to Preserve Kidney Function Over Time in FSGS - 11 months ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 3 months ago Amgen’s trial brings new hope for IgG4-RD patients - 3 months ago
10	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis - 6 months ago FDA Grants Breakthrough Therapy Designation to Nipocalimab for the Treatment of Rare Disease in Pregnancy - 7 months ago

Journalists covering fingolimod